Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-001003

10% owner bought 10,000 shares at $5.28 ($52,800)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2022-01-10 Purchase +10,000 $5.28 $52,800 4,929,413 D
Open-market purchases · 10,000 sh · avg $5.28 · $52,800
Loading xslF345X03/doc1.xml…